REG - HeiQ PLC - Director/PDMR Shareholding

HeiqAnnouncement

16/09/2024 09:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240916:nRSP3136Ea&default-theme=true

RNS Number : 3136E  HeiQ PLC  16 September 2024

 

16 September 2024

HeiQ Plc

("HeiQ" or the "Company" or the "Group")

Director's Dealings

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene
technologies, announces that Carlo Centonze, Chief Executive Officer, has
purchased 1,000,000 ordinary shares of 5p each in the Company ("Ordinary
Shares") at a price of 5p per share.

Further information is set out below pursuant to the requirements of the UK
Market Abuse Regulation.

 1    Details of the person discharging managerial responsibilities / person closely
      associated
 a)   Name                                                         Mr. Carlo Centonze
 2    Reason for the notification
 a)   Position/status                                              Chief Executive Officer
 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction
      platform, auctioneer or auction monitor
 a)   Name                                                         HeiQ plc
 b)   LEI                                                          213800IGT65IMJDO4S03
 4    Details of the transaction(s): section to be repeated for (i) each type of
      instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Ordinary shares of 5p each

      Identification code

                                                                   ISIN: GB00BN2CJ299
 b)   Nature of the transaction                                    Purchase of ordinary shares

 c)   Price(s) and volume(s)

Date               Price(s)      Volume(s)
                                                                   12 September 2024  5p per share  500,000
                                                                   13 September 2024  5p per share  500,000
 d)   Aggregated information

      - Aggregated volume                                          1,000,000 shares

      - Price                                                      5p per share

 e)   Date of the transaction                                      12(th) and 13(th) of September 2024

 f)   Place of the transaction                                     London Stock Exchange, Main Market

d)

 

Aggregated information

- Aggregated volume

- Price

 

1,000,000 shares

5p per share

 

e)

 

Date of the transaction

12(th) and 13(th) of September 2024

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

 

 

For further information, please contact:

 HeiQ Plc                                          +41 56 250 68 50

 Carlo Centonze (CEO)
 Cavendish Capital Markets Limited (Broker)        +44 (0) 207 397 8900

 Stephen Keys / Callum Davidson
 SEC Newgate (Media Enquiries)                     +44 (0) 20 3757 6882

 Elisabeth Cowell / Molly Gretton / Tom Carnegie   HeiQ@s (mailto:HeiQ@secnewgate.co.uk) ecnewgate (mailto:HeiQ@secnewgate.co.uk)
                                                   .co.uk (mailto:HeiQ@secnewgate.co.uk)

 

About HeiQ

Founded in 2005, HeiQ is a Swiss-based international company that is a global
leader in biotech ingredients and specialty chemicals for diverse applications
such as textiles, flooring, building materials, glass, plastics, probiotic
cleaning, cosmetics, and more. Working with more than 1000 partners in over 60
countries, our goal is to infuse ordinary products with extraordinary
qualities, offering our co-creation partners sustainable and disruptive
solutions across industries.

Our business model focuses on the commercialization of existing and as well as
the incubation of new technologies, driving shareholder value through sales
growth, entry into lucrative markets, and disruptive innovation. This model
consists of three distinct technology ventures, being HeiQ AeoniQ, HeiQ
Xpectra, and HeiQ GrapheneX, and three growth-orientated business units being
HeiQ Textiles & Flooring, HeiQ Life Sciences, and HeiQ Antimicrobials.

We have a robust track record of innovation, with over 200 technologies
developed in partnership with 300 major brands, including Hanes, Burberry,
HUGO BOSS, Lycra, Zara, Itochu, Bosch Siemens, Ecolab, Woellner, Americhem,
Lixil, and many more. Our global team comprises about 200 professionals from
30 nationalities across five continents. We're committed to shaping a future
where everyday products drive positive change, one innovation at a time.

To learn more about HeiQ and our innovative solutions, visit www.heiq.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFIFITAFIRLIS